560 related articles for article (PubMed ID: 27827871)
1. The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression.
Umansky V; Blattner C; Gebhardt C; Utikal J
Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27827871
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.
Sevko A; Umansky V
J Cancer; 2013; 4(1):3-11. PubMed ID: 23386900
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment and myeloid-derived suppressor cells.
Umansky V; Sevko A
Cancer Microenviron; 2013 Aug; 6(2):169-77. PubMed ID: 23242672
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers.
Lim HX; Kim TS; Poh CL
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443699
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Dysthe M; Parihar R
Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives.
Safari E; Ghorghanlu S; Ahmadi-Khiavi H; Mehranfar S; Rezaei R; Motallebnezhad M
J Cell Physiol; 2019 Jul; 234(7):9966-9981. PubMed ID: 30537008
[TBL] [Abstract][Full Text] [Related]
8. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
Salminen A; Kaarniranta K; Kauppinen A
Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
[TBL] [Abstract][Full Text] [Related]
9. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-induced immunosuppression and its neutralization.
Umansky V; Sevko A
Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
[TBL] [Abstract][Full Text] [Related]
11. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.
Yin K; Xia X; Rui K; Wang T; Wang S
Front Oncol; 2020; 10():610104. PubMed ID: 33384962
[TBL] [Abstract][Full Text] [Related]
14. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.
Talmadge JE
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5243-8. PubMed ID: 17875751
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells in malignant melanoma.
Umansky V; Sevko A; Gebhardt C; Utikal J
J Dtsch Dermatol Ges; 2014 Nov; 12(11):1021-7. PubMed ID: 25263083
[TBL] [Abstract][Full Text] [Related]
16. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
17. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
[TBL] [Abstract][Full Text] [Related]
19. Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate.
Meirow Y; Kanterman J; Baniyash M
Front Immunol; 2015; 6():523. PubMed ID: 26528286
[TBL] [Abstract][Full Text] [Related]
20. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.
Rapoport BL; Steel HC; Theron AJ; Smit T; Anderson R
Molecules; 2020 Apr; 25(7):. PubMed ID: 32244751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
